Oricell Therapeutics
Shanghai
About Oricell Therapeutics
OriCell Therapeutics develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $308.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2026)
- Website: oricell.comen
- Phone: 8621-68868119
Industries & Categories
Health Care, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/oricell-therapeutics-57820 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.